baber/WOPTO huggingface dataset:
Patent NZ-617120-A (NZ)
Title: Verification of swelling in a well
Inventor: HINKIE RONALD L
IPC: E21B33/12
Filed: 2012-05-09
Abstract: Disclosed is a method of verifying whether a swellable material (28) has swollen in a well. The method includes positioning an electrical conductor (32) proximate the swellable material (28) such that the conductor (32) parts in response to swelling of the swellable material (28). The method also includes detecting whether the conductor (32) has parted by detection of at least one electromagnetic characteristic of the conductor (32). The swellable material (28) may be part of a packer (12) and detection of the parting may indicate that the swellable material (28) has swollen sufficiently to form a seal with a surrounding wall. Arrangements are also provided for signalling a detection of the parting to a separate receiver.
Patent NZ-619167-A (NZ)
Title: Mycoplasma hyopneumoniae avirulent - adjuvanted live vaccine
Inventor: CHU HSIEN-JUE
IPC: C07K14/30
Filed: 2008-11-05
Abstract: A composition for eliciting an anti-Mycoplasma hyopneumoniae immune response in an animal, said composition comprising an immunologically effective amount of a live avirulent strain of Mycoplasma hyopneumoniae and the biologically acceptable adjuvant SP-Oil, wherein the live avirulent strain of Mycoplasma 5 hyopneumoniae is a strain whose genome comprises a nucleic acid sequence having at least 95% homology to the nucleic acid sequence of a reference Mycoplasma hyopneumoniae J strain having the GenBank Accession Number AE017243.
Patent NZ-624121-A (NZ)
Title: Boronate ester compounds and pharmaceutial compositions thereof
Inventor: ELLIOTT ERIC L
IPC: C07F5/06
Filed: 2009-06-16
Abstract: Disclosed are derivatives and analogues of 2,2’-{ 2-[(1R)-3-methyl-1-({ (2S)-3-phenyl-2-[(pyrazin- 2-ylcarbonyl)amino]propanoyl} amino)butyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl} diacetic acid of formula (II), or a pharmaceutically acceptable salt thereof, wherein: A is 0; P is pyrazin-2-ylcarbonyl; Ra is isobutyl; Ra1 is benzyl; each Rb1 and Rb2 independently is hydrogen; each Rb3 and Rb4 independently is -(CH2)p-CO2H; p is 0 or 1; and n is 0 or 1. Also disclosed is a pharmaceutical composition which comprises a compound as defined above, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, optionally with a second therapeutic agent selected from melphalan or lenalidomide, for use in treating cancer, particularly selected from multiple myeloma, or lymphoma.
Patent NZ-629001-A (NZ)
Title: Method and device for clamping a blister within a dry powder inhaler
Inventor: KENT D MOSIER
IPC: A61M15/00
Filed: 2014-03-04
Abstract: Disclosed is a medication inhaler configured to clamp a medication blister against a vibrating element. The inhaler comprises: a housing; a vibrating element within the housing; a chamber defining a flow channel communicating with the blister; a mechanism that moves a selected blister between a stowed position and a dispensing position; and a blister clamping element. The housing is configured to accommodate a plurality of individually addressable blisters carried within the housing. Each of the plurality of individually addressable blisters contains a specified amount of a medicament and has a first dome-shaped face and a second substantially flat face. The blister clamping element is configured to engage and surround, at least in part, the first dome-shaped face and to clamp the blister in the dispensing position adjacent the vibrating element. The blister clamping element is shaped to provide circumferential contact with the blister dome-shaped face to afford the blister three rotational degrees of freedom. This ensures that the blister and the vibrating element are properly engaged.
Patent NZ-702467-A (NZ)
Title: Formulations and methods for vaginal delivery of antiprogestins
Inventor: PODOLSKI JOSEPH S
IPC: A61K9/48
Filed: 2013-05-30
Abstract: The subject matter of the present invention is pertinent to the field of vaginal delivery of pharmaceutically active agents. Embodiments of the instant invention disclose methods for treating a variety of progesterone related disorders by vaginal administration of a pullulan capsule comprising one or more antiprogestins.
Patent NZ-702744-A (NZ)
Title: D-amino acid compounds for liver disease
Inventor: MAYES BENJAMIN ALEXANDER
IPC: C07H19/20
Filed: 2013-05-21
Abstract: Provided herein are compounds comprising a D-amino acid, compositions and methods for the treatment of liver disease and conditions, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.
Patent NZ-703178-A (NZ)
Title: Soy protein product with neutral or near neutral ph (”s701n2”)
Inventor: GREEN BRENT E
IPC: A23L11/00
Filed: 2013-06-25
Abstract: An aqueous solution of a soy protein product having a protein content of at least about 60 wt% (N x 6.25) d.b. which is completely soluble in aqueous media at a pH of less than about 4.4 and heat stable at that pH range is adjusted in pH to a pH of about 6.1 to about 8. The resulting product is further processed by drying the product, recovering and drying any precipitated soy protein material, heat treating and then drying the product, or heat treating the product and recovering and drying any precipitated soy protein material.
Patent NZ-703195-A (NZ)
Title: Pharmaceutical composition for inhibiting autophagy of motor neurons and use thereof
Inventor: LIN SHINN-ZONG
IPC: A61P25/14
Filed: 2012-08-17
Abstract: Disclosed is a pharmaceutical composition for inhibiting autophagy of motor neurons containing an effective amount of an active ingredient. The active ingredient is selected from the following groups: a compound of formula (I), pharmaceutically acceptable salts thereof, pharmaceutically acceptable esters thereof and a combination of the foregoing, wherein A is C1-C5 hydrocarbyl with one or more unsaturated bond as needed and is substituted by one or more substituent selected from the following groups as needed: -OΗ, =O, and C1-C3 hydrocarbyl; X is Η, -OΗ, formula (II) or formula (III); Y is O or S, and can form a five-membered ring by binding with A as needed; and R1 is H or a substituted or unsubstituted C1-C20 hydrocarbyl, wherein one or more -CH2- of the hydrocarbyl is replaced by -NH- or -O- as needed.
Patent NZ-706867-A (NZ)
Title: Improvement in or relating to capsules
Inventor: HANSEN NICHOLAS
IPC: B65D85/804
Filed: 2013-10-16
Abstract: The present invention provides a method of assembling a filter element with a cup-shaped capsule body using a combined weld-head and former that both forms and connects the filter element to the capsule body in one manufacturing process without tearing the filter, to save manufacturing time and reduce the required tooling sets and thereby improve manufacturing efficiency. The method comprising the steps of positioning the filter element (8) at or near a mouth of the cup-shaped capsule body (2), moving the combined weld-head (70) and former (80) so as to contact and drive the filter element (8) into the cup-shaped capsule body (2), wherein, the filter element (8) is deformed by a sprung- loaded former (80) of the combined weld-head (70) and former (80) to form a cup-shaped filter element (56), and using a weld-head (70) of the combined weld-head (70) and former (80) to bond the cup-shaped filter element (56) to the cup-shaped capsule body (2). The present invention further provides a method of making a beverage capsule and a beverage capsule produced using this method.
Patent NZ-710133-A (NZ)
Title: Ingenol-3-acylates iii and ingenol-3-carbamates
Inventor: GRUE-SØRENSEN GUNNAR
IPC: C07D401/04
Filed: 2011-12-22
Abstract: The disclosure relates to ingenol-3-acylate and ingenol-3-carbamate compounds of general formula I wherein R is heteroaryl optionally substituted by R7; or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8; or R is X wherein X is -NR11R12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use -alone or in combination with one or more other pharmaceutically active compounds- in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis. Conditions treated include those associated with hyperplasia or neoplasia, cutaneous warts, genitial warts, actinic keratosis, squamous cell carcinoma (SCC), basal cell carcinoma (BCC), lentigo maligna, cervical intraepithelial neoplasia, anal intraepithelial neoplasia or vulva intraepithelial neoplasia. Compounds of the disclosure include: 3-(N-methyl-N-phenyl-carbamate); and 3-(N-(3-fluoro-phenyl)-N-methyl-carbamate)
Patent NZ-715012-A (NZ)
Title: Automated body condition score measurement
Inventor: CHRIS MCMAHON
IPC: G01B5/04
Filed: 2014-12-15
Abstract: Described herein is an automated body condition score (BCS) measurement apparatus and methods of use. More specifically, an apparatus and methods of use are described that automate the process of testing an animal’s body condition score and minimise animal handling and errors in measurement of body condition score. In one embodiment, the apparatus may comprise an enclosure; an animal; at least one animal width sensor located on or about the enclosure, the at least one animal width sensor being an arm or arms extending from the enclosure side or sides that the animal contacts or nearly contacts as relative movement occurs between the animal and apparatus; and, when relative movement occurs between the animal and the at least one width sensor, the animal width and/or height is measured about at least one point along the animal body which is then used to calculate a body condition score (BCS) for the animal.
Patent NZ-718238-A (NZ)
Title: Improved eye patch
Inventor: WALLIS ANDREW
IPC: A61F13/12
Filed: 2014-08-22
Abstract: There is a need for a surgical eye patch that reduces the damage to the upper and lower eyelids or skin adjacent to the eye. Provided is an eye patch for releasable mounting to a face of a patient, used to retain eyelids of said patient closed during a medical procedure, including a first portion having a first adhesive coating for attachment to the face of said patient adjacent an edge of the patent’s eye socket, the first portion including a central opening extending therethrough, and a second portion extending over said central opening and having a second adhesive coating for attachment to the eyelids of said patient, the second portion being transparent and extending over said patient’s eyelids when closed, such that said eyelids can be observed during a medical procedure, wherein the adhesive bond strength of the second adhesive coating is weaker than the adhesive bond strength of the first adhesive coating, whereby the first adhesive coating retains the eye patch in position on said face during the medical procedure, and the second adhesive coating restraining the eyelids from opening, while inhibiting injury to the patient’s face when the eye patch is removed. The eye patch is removable in a sideways or lateral direction. There is also provided a method of constructing a single use sterile dressing and a method of use thereof.
Patent NZ-729330-A (NZ)
Title: Fuel cell adaptor for combustion fastener driver
Inventor: VANSTAAN VALERY H
IPC: B25C1/08
Filed: 2014-12-08
Abstract: In a fuel delivery system for a combustion fastener driver a fuel cell adapter may be used in conjunction with a fuel cell with the aim of a more consistent relationship between the fuel cell and a corresponding tool actuator mechanism. In one form the adapter has a generally planar flange and defining a main opening, and a collar suspended in the opening by a suspension connected to the collar and to a ring in the flange defining the opening. The suspension includes a plurality of support arms each connected at one end to the collar and at an opposite end to the ring such that the collar is connected to the flange only by the suspension. Advantageously, each arm may be constructed to permit the collar only a limited vertical travel and even more restricted non-vertical movement. By permitting limited vertical movement of the collar, the fuel cell adapter enhances the engagement between the stem receiver block and the fuel cell valve stem.
Patent NZ-731349-A (NZ)
Title: Device and method for dispensing a drug
Inventor: HOFLAND HANS
IPC: A61M35/00
Filed: 2015-09-29
Abstract: A device (10) for dispensing a topically administered drug has a spreader (14) which is used to actuate a pump (16) to release the drug and then to spread the drug on the skin. The spreader is coupled to a lock (50) that prevents it from actuating the pump after a number of drug doses have been dispensed. The pump can be actuated to release no more than the selected quantity of drug per day or actuation. The prior art has a possible deficiency that the amount of drug being administered is hard to control. This invention addresses that problem by allowing the user to control the amount and location of drug or active ingredient that is dispensed by the user.
Patent NZ-735001-A (NZ)
Title: Nesting container carrier
Inventor: ZAKARY JAMES BORG
IPC: B65D71/70
Filed: 2017-08-28
Abstract: A container carrier and manufacturing method therefore are provided. The container carrier may include an integrally molded body with a graspable loop and plurality of annular structures connected by bridges. Each annular structure may include a side wall formed of side wall portions separated by side wall voids. Each side wall portion has an upper and a lower side wall segment joined at a ledge, with the upper side wall segment having a smaller diameter relative to the lower side wall segment of the side wall portion. The graspable loop is configured to extend above a top surface of the container carrier in an unbiased configuration to provide an easily graspable carrying mechanism. Inwardly projecting and upwardly oriented flanges are positioned at the bottom of each side wall void to collectively engage containers. The bottom portion of the lower side wall segment has an inner diameter that is larger than the outer diameter of the upper side wall and smaller than the outer diameter of the ledge such that the bottom of a first container carrier will rest upon the ledge of a second, same-shaped container carrier when stacked.
Patent NZ-736450-A (NZ)
Title: 1-cyano-pyrrolidine compounds as usp30 inhibitors
Inventor: JONES ALISON
IPC: C07D403/12
Filed: 2016-03-24
Abstract: The present invention relates to novel compounds and method for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase 30 (USP30). The invention further relates to the use of DUB inhibitors in the treatment of conditions involving mitochondrial dysfunction and cancer. Compounds of the invention include compounds having the formula (II) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R8, R9, R10, R12, Z, Y and m are as defined herein.
Patent NZ-737435-A (NZ)
Title: Prodrugs of fumarates and their use in treating various diseases
Inventor: DUNCAN SCOTT
IPC: A61K31/221
Filed: 2014-03-14
Abstract: Disclosed are sulfonyl prodrugs of fumaric acid esters or fumarates of formula (Ia) where variables are as disclosed in the specification. The compounds are useful in the treatment of neurological diseases such as multiple sclerosis.
Patent NZ-738402-A (NZ)
Title: A filtering apparatus comprising an inlet and at least two outlets
Inventor: LEE SEE ANTON
IPC: C02F1/38
Filed: 2016-06-09
Abstract: An apparatus for filtering solid and/or non-dissolved contaminants entrained in flowing water, the apparatus comprising an inlet for the water containing the entrained solid or non-dissolved contaminants to flow into a filtering chamber; a first outlet for expelling the unfiltered water from the filtering chamber; a housing positioned relative to the filtering chamber; the filtering chamber further comprising: a curved or corner portion in the filtering chamber providing a generally U-shaped flow path for water flowing from the first inlet to the first outlet and wherein the curved or corner portion causes the water to flow in the opposite direction when the water flows along the curved or corner portion, the curved portion or corner portion providing at least a part of the flow path that leads from the first inlet to the first outlet; and a filtering screen for filtration of solid and/or non-dissolved contaminants from the influent water thereby allowing passage of filtered water out of the filtering chamber. The apparatus is characterised in that a substantially flat perforated wall or side or portion thereof of the filtering chamber forms an in use floor of the filtering chamber for filtration of debris from the influent water. There has been a long felt need for conventional rain water filters to achieve comparatively high catchment efficiency. The invention aims to the change of direction of the water flow in the apparatus to slow down the flow of water through the chamber and increase the overall residence time in the filtering chamber.
Patent NZ-738983-A (NZ)
Title: Reference signal in a communications network
Inventor: SAHLIN HENRIK
IPC: H04L5/02
Filed: 2015-07-14
Abstract: Reference signals represent an overhead that increases packet data latency and power consumption when transmitted in Physical Uplink Shared Channel subframes, and should be reduced. Disclosed herein is a method (110) in a user equipment (105) for transmitting a demodulation reference signal in a communications network. The method comprises a step of determining (111) multiplexing information for the demodulation reference signal. The method further comprises a step of transmitting (113) the demodulation reference signal using the multiplexing information in a same time allocation as a demodulation reference signal of another user equipment. The method further comprises a step of transmitting (115) data symbols associated with the demodulation reference signal in a separate time allocation of physical resources, and on a same physical frequency resource, to a time allocation of data symbols of the said another user equipment.
Patent NZ-741132-A (NZ)
Title: Polymer conjugate comprising a bioactive agent
Inventor: TAIT RUSSELL
IPC: A61K47/60
Filed: 2016-09-09
Abstract: The present invention relates to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent conjugates contain triazole moieties in the polymer backbone and a bioactive moiety selected from quinolones, NSAIDs and mixtures thereof. The conjugates are a co-polymer of at least one monomer according to formula (IV) and a monomer of formula (V), wherein the latter monomer comprises a 3-arm or 4-arm branched polyether linker derived from polyethylene glycol. The present invention also relates to methods for preparing the polymer conjugates using click cycloaddition chemical reactions, to monomer-bioactive agent conjugates suitable for preparing the polymer conjugates, and to pharmaceutical products comprising the polymer conjugates for the post-surgical care to treat or prevent infections, provide analgesia and treat inflammation.
Patent NZ-759178-A (NZ)
Title: Method for configuring transmission direction of time-frequency resource, and apparatus
Inventor: ZHANG LILI
IPC: H04W72/04
Filed: 2017-05-05
Abstract: The present application provides a method and device for configuring a time-frequency resource transmission direction. A terminal device receives first configuration information sent by a first access network device and/or second configuration information sent by a second access network device, and transmits data according to the first configuration information and/or the second configuration information, wherein the first configuration information comprises configuration information of a transmission direction of the first access network device on at least one resource unit, the second configuration information comprises configuration information of a transmission direction of the second access network device on at least one resource unit, and the at least one resource unit comprises at least one of a frequency domain unit, a time domain unit, or a spatial domain unit. In the method, the number of resource units comprised in one cycle is not limited, a greater variety of resource unit types may be comprised, and a greater number and variety of correspondence types of resource units to distribution modes is possible, that is, configuration modes or structures are more diverse. Therefore, configuration of a transmission direction of a time-frequency space resource is more flexible, making it possible to handle dynamic changes in service requirements.
Patent NZ-775585-A (NZ)
Title: Combination pillow and sleeping bag or blanket or comforter
Inventor: SUTTON JOSEPH
IPC: A63H3/00
Filed: 2020-10-09
Abstract: A combination pillow and sleeping bag (10) is described. The combination pillow and sleeping bag is configurable between a first configuration and a second configuration. The combination pillow and sleeping bag includes a first pillow portion (18) and a second pillow portion (22) detachably coupled to the first pillow portion. The second pillow portion defines a cavity (24). The combination pillow and sleeping bag also includes a sleeping bag (50) having a first end (54) coupled to the first pillow portion (18) and a second end (58) coupled to the second pillow portion (22). When in the first configuration, the first and second pillow portions are coupled together and the sleeping bag is positioned within the cavity of the second pillow portion. When in the second configuration, the first and second pillow portions are detached from one another and spaced apart such that the sleeping bag extends between the first and second pillow portions.
Patent PT-103924-A (PT)
Title: Motor de calor com recuperação do calor sensível e do calor latente
IPC: F03B3/00
Filed: 2008-01-08
Abstract: O PRESENTE INVENTO REFERE-SE A UM MOTOR DE CALOR COM RECUPERAÇÃO DO CALOR SENSÍVEL E DO CALOR LATENTE PARA TRANSFORMAÇÃO DE ENERGIA POTENCIAL DE UM FLUIDO EM OUTRAS FORMAS DE ENERGIA, QUE COMBINA UMA FONTE CALOR (1), CILINDRO/PISTON OU TURBINA DE REACÇÃO (2), UM PERMUTADOR DE CALOR (3), COM UM EJECTOR-COMPRESSOR (4), DOIS CONDENSADORES (5,6), BOMBA DE PRESSÃO E CIRCULAÇÃO (7) E UMA FLUIDO REFRIGERANTE NA TRANSFERÊNCIA DE CALOR E ENERGIA ENTRE OS DIFERENTES COMPONENTES, E COM AS RESPECTIVAS VÁLVULAS E CONTROLES. A RECUPERAÇÃO DO CALOR SENSÍVEL E LATENTE NOS DIVERSOS PERMUTADORES É A SUA PRINCIPAL CARACTERÍSTICA.